IL5 and Alzheimer disease: The observed reduced levels of CD4+ cells in the skin of compound 1- and 2-treated AD-induced mice could be a reason for the reduced IL-4 and IL-5 levels in these experimental animals, as compared to the DNCB-alone treated mice.